Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-02-06 | New | $1,096,500 | $1,096,500 | Equity Only | 06b | SEC link |
| 2023-01-24 | New | $300,000 | $300,000 | Equity Only | 06b | SEC link |
| 2019-05-03 | New | Yet to Sell | $0 | Equity and Debt | 06b 4a5 | SEC link |
| 2016-11-23 | Amended | $1,691,118 | $1,391,118 | Equity Only | 06b 4a5 | SEC link |
| 2016-01-19 | New | $300,000 | $300,000 | Equity Only | 06b | SEC link |
| 2012-10-23 | New | Yet to Sell | $0 | Equity Only | 06 46 | SEC link |
| 2011-05-24 | Amended | Yet to Sell | $0 | Equity Only | 06 46 | SEC link |
| 2010-12-15 | New | Yet to Sell | $0 | Equity Only | 06 46 | SEC link |
| 2009-06-23 | New | $565,510 | Unknown | Equity Only | 06 46 | SEC link |
| Name | Role |
|---|---|
| Timothy L. Claxton | Director |
| Todd O. Davis | Director |
| Paul Gilbert | Director |
| Scott Glaze | Director |
| Brian Curtis Hodorek | Director |
| Douglas Kampen | Director |
| Karl La Pan | Director |
| Karl Lapan | Director |
| Christopher L. Mapes | Director |
| Roger Muselman | Director |
| Sabra Rowley | Director, Executive |
| Ryan Schlotterback | Executive |
| Sheila Schwartz | Director, Executive |
| Herbert E. Schwartz | Director, Executive |
| Company Schwartz Biomedical, Llc | Promoter |
| Richard Tarr | Director |
| Robert E. Vitoux, Jr. | Director |